Header Logo

Connection

ANNA MANDALAKAS to Piperazines

Back to Details
This is a "connection" page, showing publications ANNA MANDALAKAS has written about Piperazines.
ANNA MANDALAKAS
Connection Strength
0.039
Piperazines
  1. Transition to Dolutegravir Is Associated With an Increase in the Rate of Body Mass Index Change in a Cohort of Virally Suppressed Adolescents. Clin Infect Dis. 2021 08 02; 73(3):e580-e586.
    View in: PubMed
    Score: 0.039
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.